Comparative trial of efficacy of trimethasidine MB and 3-(2,2,2-trimethylhydrasine) propionate dihydrate in chronic heart failure

被引：0
|
作者：
Vasyuk, Yu. A.
Yuschuk, E. N.
Shkolnik, E. L.
Khadzegova, A. B.
Sadulaeva, I. A.
Vitko, N. X.
Vakhromeeva, M. N.
机构：
来源：
TERAPEVTICHESKII ARKHIV | 2007年 / 79卷 / 02期
关键词：
chronic heart failure; myocardial metabolism; hybernation; trimethasidine MB; 3-(2,2,2-trimethylhydrasinium) propionate dihydrate; positron-emission tomography;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：51 / 58
页数：8
相关论文
共 50 条
  • [1] ELECTROMEMBRANE SYNTHESIS OF 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE
    VASILEV, VN
    OMELCHENKO, YN
    TKACH, IN
    PUGOVICH, OV
    KALVINSH, IY
    JOURNAL OF APPLIED CHEMISTRY OF THE USSR, 1992, 65 (12): : 2351 - 2352
  • [2] 3-(Benzimidazolium-2-yl)propionate dihydrate
    Xiao, Xin
    Zhang, Yun-Qiang
    Xue, Sai-Feng
    Tao, Zhu
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2008, 64 : O2066 - U1448
  • [3] INVERSION VOLTAMMETRIC DETERMINATION OF DIHYDRATE-3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE
    IVANOVSKAYA, EA
    ANISIMOVA, LS
    JOURNAL OF ANALYTICAL CHEMISTRY, 1992, 47 (09) : 1228 - 1231
  • [4] Pharmacokinetics and biological fate of 3-(2,2,2-trimethylhydrazinium) propionate dihydrate (MET-88), a novel cardioprotective agent, in rats
    Yoshisue, K
    Yamamoto, Y
    Yoshida, K
    Saeki, M
    Minami, Y
    Esumi, Y
    Kawaguchi, Y
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (06) : 687 - 694
  • [5] EXPERIMENTAL-STUDY OF INTERFERON-INDUCING AND ANTIINFLUENZA PROPERTIES OF 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE
    KREMERMAN, IB
    PRIYMYAGI, LS
    KALVINSH, IY
    LUKEVITS, EY
    VOPROSY VIRUSOLOGII, 1987, (05) : 576 - 579
  • [6] 3-(2,2,2-TRIMETHYLHYDRAZINIUM)PROPIONATE (THP) - A NOVEL GAMMA-BUTYROBETAINE HYDROXYLASE INHIBITOR WITH CARDIOPROTECTIVE PROPERTIES
    SIMKHOVICH, BZ
    SHUTENKO, ZV
    MEIRENA, DV
    KHAGI, KB
    MEZAPUKE, RJ
    MOLODCHINA, TN
    KALVINS, IJ
    LUKEVICS, E
    BIOCHEMICAL PHARMACOLOGY, 1988, 37 (02) : 195 - 202
  • [7] Comparative trial of efficacy and safety of cardosten, valsartan and their combination in patients with chronic heart failure
    Zabolotneva, Y. U.
    Kachanova, M.
    Petrov, V. I.
    Arutyunov, G. P.
    Yevzirikhina, A. V.
    Nedogoda, S. V.
    Lopatin, Y. U. M.
    Tsoma, V. V.
    Sergeeva, S. A.
    Epstein, O. I.
    EUROPEAN HEART JOURNAL, 2011, 32 : 787 - 787
  • [8] Pharmacokinetic analysis of the cardioprotective effect of 3-(2,2,2-trimethylhydrazinium) propionate in mice: Inhibition of carnitine transport in kidney
    Kuwajima, M
    Harashima, H
    Hayashi, M
    Ise, S
    Sei, M
    Lu, KM
    Kiwada, H
    Sugiyama, Y
    Shima, K
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1999, 289 (01): : 93 - 102
  • [9] BIOCHEMICAL CHARACTERISTICS OF THE ANTIISCHEMIC EFFECT OF A NEW STRUCTURAL ANALOG OF GAMMA-BUTYROBETAINE 3-(2,2,2-TRIMETHYLHYDRAZINI)PROPIONATE
    SIMKHOVICH, BZ
    MEIRENA, DV
    HAGI, HB
    KALVINSH, IY
    LUKEVITS, EY
    FARMAKOLOGIYA I TOKSIKOLOGIYA, 1987, 50 (02): : 100 - 104
  • [10] REGULATION OF CARNITINE DEPENDENT METABOLISM OF FATTY-ACIDS IN RAT MYOCARDIUM USING 3-(2,2,2-TRIMETHYL HYDRAZINIUM) PROPIONATE
    SHUTENKO, ZV
    SIMKHOVICH, BZ
    MEYRENA, DV
    KALVINSH, NY
    LUKEVITZ, EY
    VOPROSY MEDITSINSKOI KHIMII, 1989, 35 (02): : 59 - 64
12345